197 related articles for article (PubMed ID: 1682484)
1. Cardiac effects of beta-2 adrenoceptor stimulation with intracoronary procaterol in the absence and presence of regional myocardial ischemia in dogs.
Noguchi K; Ojiri Y; Chibana T; Moromizato H; Sakanashi M
J Pharmacol Exp Ther; 1991 Nov; 259(2):732-7. PubMed ID: 1682484
[TBL] [Abstract][Full Text] [Related]
2. Beta 2-adrenoceptor-mediated positive dromotropic effects on atrioventricular node of dogs.
Motomura S; Hashimoto K
Am J Physiol; 1992 Jan; 262(1 Pt 2):H123-9. PubMed ID: 1346356
[TBL] [Abstract][Full Text] [Related]
3. Alpha adrenoceptor regulation of coronary artery blood flow in normal and stenotic canine coronary arteries.
Kopia GA; Kopaciewicz LJ; Ruffolo RR
J Pharmacol Exp Ther; 1986 Dec; 239(3):641-7. PubMed ID: 2879028
[TBL] [Abstract][Full Text] [Related]
4. Differential coupling to positive inotropic responses of cyclic AMP produced by stimulation of beta 1- and beta 2-adrenergic receptors.
Yanagisawa T; Ishii K; Hashimoto H; Taira N
J Cardiovasc Pharmacol; 1989 Jan; 13(1):64-75. PubMed ID: 2468937
[TBL] [Abstract][Full Text] [Related]
5. Responses to the beta 2-selective agonist procaterol of vascular and atrial preparations with different functional beta-adrenoceptor populations.
O'Donnell SR; Wanstall JC
Br J Pharmacol; 1985 Jan; 84(1):227-35. PubMed ID: 2858232
[TBL] [Abstract][Full Text] [Related]
6. The classification of beta-adrenoceptors in isolated ring preparations of canine coronary arteries.
O'Donnell SR; Wanstall JC
Br J Pharmacol; 1984 Apr; 81(4):637-44. PubMed ID: 6144344
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotective effects of hydrolyzed bopindolol against contractile dysfunction produced by coronary stenosis and reperfusion in dogs.
Noguchi K; Aniya Y; Ojiri Y; Chibana T; Matsuzaki T; Shiroma N; Fong KF; Uza M; Sakanashi M
Arch Int Pharmacodyn Ther; 1994; 327(3):279-93. PubMed ID: 7848012
[TBL] [Abstract][Full Text] [Related]
8. Alleviation of myocardial dysfunction and abnormal lactate metabolism during coronary stenosis in dogs by ICI 118,551.
Noguchi K; Ojiri Y; Nagamine F; Matsuzaki T; Sakanashi M
Eur J Pharmacol; 1989 Sep; 168(3):315-28. PubMed ID: 2583239
[TBL] [Abstract][Full Text] [Related]
9. Agonist-induced desensitization of beta-adrenoceptor function in humans. Subtype-selective reduction in beta 1- or beta 2-adrenoceptor-mediated physiological effects by xamoterol or procaterol.
Brodde OE; Daul A; Michel-Reher M; Boomsma F; Man in 't Veld AJ; Schlieper P; Michel MC
Circulation; 1990 Mar; 81(3):914-21. PubMed ID: 1968366
[TBL] [Abstract][Full Text] [Related]
10. Effects of nipradilol on myocardial ischaemia produced by coronary stenosis in dogs.
Noguchi K; Sakanashi M
Br J Pharmacol; 1987 Jun; 91(2):411-9. PubMed ID: 2886171
[TBL] [Abstract][Full Text] [Related]
11. Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog.
Berlan M; Galitzky J; Bousquet-Melou A; Lafontan M; Montastruc JL
J Pharmacol Exp Ther; 1994 Mar; 268(3):1444-51. PubMed ID: 7908057
[TBL] [Abstract][Full Text] [Related]
12. Characterization of beta-adrenoceptor subtypes in the ferret urinary bladder in vitro and in vivo.
Takeda H; Igawa Y; Komatsu Y; Yamazaki Y; Akahane M; Nishizawa O; Ajisawa Y
Eur J Pharmacol; 2000 Sep; 403(1-2):147-55. PubMed ID: 10969156
[TBL] [Abstract][Full Text] [Related]
13. Coronary artery vasodilation in the canine: physiological and pharmacological roles of beta-adrenergic receptors.
Jackson CV; Pope TK; Lucchesi BR
J Cardiovasc Pharmacol; 1987 Aug; 10(2):196-204. PubMed ID: 2441171
[TBL] [Abstract][Full Text] [Related]
14. Effect of beta-adrenoceptor stimulation or blockade on regional myocardial function and regional O2 consumption during myocardial ischemia.
Grover GJ; Kostis JB; Weiss HR; Li JK; Kovacs T; Kedem J
Arch Int Pharmacodyn Ther; 1988; 291():68-87. PubMed ID: 2896490
[TBL] [Abstract][Full Text] [Related]
15. Human myocardial beta-adrenoceptors: demonstration of both beta 1- and beta 2-adrenoceptors mediating contractile responses to beta-agonists on the isolated right atrium.
Zerkowski HR; Ikezono K; Rohm N; Reidemeister JC; Brodde OE
Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):142-7. PubMed ID: 2871495
[TBL] [Abstract][Full Text] [Related]
16. Lipomobilizing effects of procaterol and yohimbine in the conscious dog: comparison of endocrinological, metabolic and cardiovascular effects.
Valet P; Taouis M; Tran MA; Montastruc P; Lafontan M; Berlan M
Br J Pharmacol; 1989 May; 97(1):229-39. PubMed ID: 2566353
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of alpha 2-adrenoceptor activity on ischemic myocardium during coronary hypoperfusion in dogs.
Kitakaze M; Hori M; Gotoh K; Sato H; Iwakura K; Kitabatake A; Inoue M; Kamada T
Circ Res; 1989 Dec; 65(6):1632-45. PubMed ID: 2555078
[TBL] [Abstract][Full Text] [Related]
18. Effects of denopamine with or without diltiazem on the ischemic heart of anesthetized dogs.
Chibana T; Noguchi K; Ojiri Y; Matsuzaki T; Nakasone J; Uezu K; Itomine T; Higuchi M; Sakanashi M
Jpn Heart J; 1992 Nov; 33(6):829-42. PubMed ID: 1363733
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of beta-adrenoceptor subtypes in the canine and rat lower urinary tract.
Takeda H; Matsuzawa A; Igawa Y; Yamazaki Y; Kaidoh K; Akahane S; Kojima M; Miyata H; Akahane M; Nishizawa O
J Urol; 2003 Aug; 170(2 Pt 1):654-8. PubMed ID: 12853850
[TBL] [Abstract][Full Text] [Related]
20. Glibenclamide prevents coronary vasodilation induced by beta 1-adrenoceptor stimulation in dogs.
Narishige T; Egashira K; Akatsuka Y; Imamura Y; Takahashi T; Kasuya H; Takeshita A
Am J Physiol; 1994 Jan; 266(1 Pt 2):H84-92. PubMed ID: 7905717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
